U.S. castrate resistant prostate cancer market statistics, by therapy, 2016-2027 (USD Million)
US castrate-resistant prostate cancer market size was valued at 3,279.1 USD million in 2017 and is estimated to grow at a compound annual growth rate (CAGR) of 5.8% from 2018 to 2027.